merck oral glp-1 Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Receptor Agonist GLP-1 Medication-Offering Health Platforms: Futurhealth

By 2026, its predicted that 10 million people in the US will have used a GLP-1 drug for losing weight, and this number is expected to grow to about 48 million by 2030

These actions improve glucose control in type 2 diabetes patients who have weak GLP-1 response

otherwise, no significant liraglutide effects on cardiovascular biomarkers were observed at year 1

GLP-1 medications can help manage blood sugar levels, reduce appetite, and support weight loss

One study found that dose-related local skin reactions were more common in patients treated with albiglutide compared to twice-daily exenatide or placebo

L.BartoliN.ToffanelloG.RagghiantiB.et al (2012)